Cargando…

Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience

ABSTRACT: Introduction: Hepatocellular carcinoma (HCC) represents a major health concern worldwide; identifying risk factors and associated conditions that may lead to its development are therefore of utmost importance to the medical community. An association between diabetes mellitus (DM) and devel...

Descripción completa

Detalles Bibliográficos
Autores principales: BRAIA, N., STREBA, C.T., ALEXANDRU, D.O., VERE, C.C., ROGOVEANU, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256165/
https://www.ncbi.nlm.nih.gov/pubmed/30568830
http://dx.doi.org/10.12865/CHSJ.42.02.10
_version_ 1783374093759807488
author BRAIA, N.
STREBA, C.T.
ALEXANDRU, D.O.
VERE, C.C.
ROGOVEANU, I.
author_facet BRAIA, N.
STREBA, C.T.
ALEXANDRU, D.O.
VERE, C.C.
ROGOVEANU, I.
author_sort BRAIA, N.
collection PubMed
description ABSTRACT: Introduction: Hepatocellular carcinoma (HCC) represents a major health concern worldwide; identifying risk factors and associated conditions that may lead to its development are therefore of utmost importance to the medical community. An association between diabetes mellitus (DM) and development of HCC on underlying liver conditions has been previously suggested. The aim of our study is to reveal possible significant statistical correlations between the two entities, which might warrant further study of the pathophysiological mechanisms behind this association. Patients and methods: We have prospectively included consecutive cirrhotic patients admitted to our medical clinic over a period of four years, between 2010 and 2014. Diagnostic was established using the EASL criteria. We have documented history of hyperglycemia and any changes of serum values in these patients, evaluating DM patients within the LC lot. From these patients we have selected all patients with imaging suggestive for HCC and established positive diagnosis on the criteria established in the latest EASL guidelines. We have used statistical tests to identify possible correlations between these pathologies. Results: We have identified 2718 consecutive patients with LC and successfully included 2556. Of these, 164 also had HCC. A total of 371 patients had DM – 54 also had HCC while 317 remained cancer-free through our study period. We found positive correlations between the presence of DM and HCC. Subgroup analysis of the HCC cohort revealed a positive association between DM and liver cirrhosis and chronic hepatitis. We did not find positive relationships between DM and overall liver conditions, splenomegaly, hepatomegaly, other significant symptoms, substance abuse and main serum values. Conclusions: We have found several significant correlations between DM and underlying liver conditions in a HCC cohort. Our study, however, did not reveal other significant associations regarding these diseases. Further studies are required to determine the precise role this disease plays in the development and severity of liver diseases.
format Online
Article
Text
id pubmed-6256165
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medical University Publishing House Craiova
record_format MEDLINE/PubMed
spelling pubmed-62561652018-12-19 Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience BRAIA, N. STREBA, C.T. ALEXANDRU, D.O. VERE, C.C. ROGOVEANU, I. Curr Health Sci J Original Paper ABSTRACT: Introduction: Hepatocellular carcinoma (HCC) represents a major health concern worldwide; identifying risk factors and associated conditions that may lead to its development are therefore of utmost importance to the medical community. An association between diabetes mellitus (DM) and development of HCC on underlying liver conditions has been previously suggested. The aim of our study is to reveal possible significant statistical correlations between the two entities, which might warrant further study of the pathophysiological mechanisms behind this association. Patients and methods: We have prospectively included consecutive cirrhotic patients admitted to our medical clinic over a period of four years, between 2010 and 2014. Diagnostic was established using the EASL criteria. We have documented history of hyperglycemia and any changes of serum values in these patients, evaluating DM patients within the LC lot. From these patients we have selected all patients with imaging suggestive for HCC and established positive diagnosis on the criteria established in the latest EASL guidelines. We have used statistical tests to identify possible correlations between these pathologies. Results: We have identified 2718 consecutive patients with LC and successfully included 2556. Of these, 164 also had HCC. A total of 371 patients had DM – 54 also had HCC while 317 remained cancer-free through our study period. We found positive correlations between the presence of DM and HCC. Subgroup analysis of the HCC cohort revealed a positive association between DM and liver cirrhosis and chronic hepatitis. We did not find positive relationships between DM and overall liver conditions, splenomegaly, hepatomegaly, other significant symptoms, substance abuse and main serum values. Conclusions: We have found several significant correlations between DM and underlying liver conditions in a HCC cohort. Our study, however, did not reveal other significant associations regarding these diseases. Further studies are required to determine the precise role this disease plays in the development and severity of liver diseases. Medical University Publishing House Craiova 2016 2016-06-28 /pmc/articles/PMC6256165/ /pubmed/30568830 http://dx.doi.org/10.12865/CHSJ.42.02.10 Text en Copyright © 2016, Medical University Publishing House Craiova http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
BRAIA, N.
STREBA, C.T.
ALEXANDRU, D.O.
VERE, C.C.
ROGOVEANU, I.
Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title_full Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title_fullStr Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title_full_unstemmed Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title_short Hepatocellular Carcinoma in Diabetic Patients - a Single Center Experience
title_sort hepatocellular carcinoma in diabetic patients - a single center experience
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256165/
https://www.ncbi.nlm.nih.gov/pubmed/30568830
http://dx.doi.org/10.12865/CHSJ.42.02.10
work_keys_str_mv AT braian hepatocellularcarcinomaindiabeticpatientsasinglecenterexperience
AT strebact hepatocellularcarcinomaindiabeticpatientsasinglecenterexperience
AT alexandrudo hepatocellularcarcinomaindiabeticpatientsasinglecenterexperience
AT verecc hepatocellularcarcinomaindiabeticpatientsasinglecenterexperience
AT rogoveanui hepatocellularcarcinomaindiabeticpatientsasinglecenterexperience